Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) Equity Average (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Equity Average for 10 consecutive years, with $16.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average fell 9.46% to $16.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $16.5 million, a 9.46% decrease, with the full-year FY2024 number at $18.6 million, down 28.08% from a year prior.
  • Equity Average was $16.5 million for Q3 2025 at KORU Medical Systems, roughly flat from $16.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $37.5 million in Q2 2021 to a low of $16.4 million in Q2 2025.
  • A 5-year average of $27.2 million and a median of $28.9 million in 2023 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: skyrocketed 322.16% in 2021, then tumbled 35.42% in 2024.
  • KORU Medical Systems' Equity Average stood at $36.6 million in 2021, then fell by 12.94% to $31.9 million in 2022, then decreased by 25.12% to $23.9 million in 2023, then dropped by 27.7% to $17.3 million in 2024, then dropped by 4.5% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Equity Average are $16.5 million (Q3 2025), $16.4 million (Q2 2025), and $16.6 million (Q1 2025).